➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for SGN-15

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug SGN-15?

SGN-15 is an investigational drug.

There have been 73 clinical trials for SGN-15. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2010.

The most common disease conditions in clinical trials are Lymphoma, Lymphoma, Non-Hodgkin, and Hodgkin Disease. The leading clinical trial sponsors are Seattle Genetics, Inc., Millennium Pharmaceuticals, Inc., and Genentech, Inc.

Recent Clinical Trials for SGN-15
A Study of SGN-B6A in Advanced Solid TumorsSeattle Genetics, Inc.Phase 1
A Safety Study of SGN-TGT in Patients With Advanced CancerSeattle Genetics, Inc.Phase 1
A Study of SGN-CD228A in Advanced Solid TumorsSeattle Genetics, Inc.Phase 1

See all SGN-15 clinical trials

Clinical Trial Summary for SGN-15

Top disease conditions for SGN-15
Top clinical trial sponsors for SGN-15

See all SGN-15 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.